ArticleCancers2024
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition.
Roberto Piva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancers2024
Roberto Piva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.